Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.
Ontology highlight
ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, metabolic syndrome, and type II diabetes mellitus. Recently, circulating microRNAs (miRNAs) have been proposed as useful disease biomarkers. We examined whether circulating miRNAs, such as miR-20a, miR-27a, and miR-126, were useful biomarkers for NAFLD. We conducted a cross-sectional analysis of 527 subjects aged 39 years or older who had undergone a health examination in the Yakumo Study. Of the residents, 92 were diagnosed with NAFLD using a registered medical sonographer. Serum miR-20a, miR-27a and miR-126 levels were measured by quantitative real-time PCR. We then calculated the odds ratios for serum miRNA level changes according to the severity of NAFLD using normal liver status as the reference group. Serum
SUBMITTER: Ando Y
PROVIDER: S-EPMC6906495 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA